OBJECTIVE: To evaluate the hypothesis that patients with schizophrenia who have been treated with neuroleptics have a high rate of Alzheimer's disease-like neuropathology. METHOD: Neuropathological studies indicating the presence or absence of Alzheimer's disease-like neuropathology in the postmortem brains of patients with schizophrenia, normal comparison subjects, and comparison subjects who had affective disorder were evaluated with Mantel-Haenszel chi-square and odds ratio analyses. RESULTS: Ten studies with relevant data were reviewed; none of eight with comparisons indicated that Alzheimer's disease-like neuropathology was more likely to be found in the brains of patients with schizophrenia than in the brains of comparison subjects. CONCLUSIONS: Suggestions that cerebral plaques and neurofibrillary tangles are more common in schizophrenia in association with neuroleptic treatment were not supported.
OBJECTIVE: To evaluate the hypothesis that patients with schizophrenia who have been treated with neuroleptics have a high rate of Alzheimer's disease-like neuropathology. METHOD: Neuropathological studies indicating the presence or absence of Alzheimer's disease-like neuropathology in the postmortem brains of patients with schizophrenia, normal comparison subjects, and comparison subjects who had affective disorder were evaluated with Mantel-Haenszel chi-square and odds ratio analyses. RESULTS: Ten studies with relevant data were reviewed; none of eight with comparisons indicated that Alzheimer's disease-like neuropathology was more likely to be found in the brains of patients with schizophrenia than in the brains of comparison subjects. CONCLUSIONS: Suggestions that cerebral plaques and neurofibrillary tangles are more common in schizophrenia in association with neuroleptic treatment were not supported.
Authors: Salma R I Ribeiz; Débora P Bassitt; Jony A Arrais; Renata Avila; David C Steffens; Cássio M C Bottino Journal: CNS Drugs Date: 2010-04 Impact factor: 5.749
Authors: Jun Ku Chung; Shinichiro Nakajima; Eric Plitman; Yusuke Iwata; Danielle Uy; Philip Gerretsen; Fernando Caravaggio; M Mallar Chakravarty; Ariel Graff-Guerrero Journal: Am J Geriatr Psychiatry Date: 2016-04-29 Impact factor: 4.105
Authors: Michael A Rapp; Michal Schnaider-Beeri; Dushyant P Purohit; Abraham Reichenberg; Susan R McGurk; Vahram Haroutunian; Philip D Harvey Journal: Schizophr Res Date: 2010-01 Impact factor: 4.939
Authors: J R Bustillo; L M Rowland; P Mullins; R Jung; H Chen; C Qualls; R Hammond; W M Brooks; J Lauriello Journal: Mol Psychiatry Date: 2009-11-17 Impact factor: 15.992
Authors: A Schmitt; M Bauer; H Heinsen; W Feiden; P Falkai; I Alafuzoff; T Arzberger; S Al-Sarraj; J E Bell; N Bogdanovic; W Brück; H Budka; I Ferrer; G Giaccone; G G Kovacs; D Meyronet; M Palkovits; P Parchi; E Patsouris; R Ravid; R Reynolds; P Riederer; W Roggendorf; A Schwalber; D Seilhean; H Kretzschmar Journal: J Neural Transm (Vienna) Date: 2006-12-14 Impact factor: 3.575
Authors: Christina Josefa Herold; Marc Montgomery Lässer; Lena Anna Schmid; Ulrich Seidl; Li Kong; Iven Fellhauer; Philipp Arthur Thomann; Marco Essig; Johannes Schröder Journal: Front Psychiatry Date: 2015-04-21 Impact factor: 4.157